Arterex today announced its acquisition of Micromold and said it would move the medtech supplier’s operations from Riverside, California to Tecate, Mexico.

Micromold manufactures custom precision micromolded parts. The company has 20 BOY Machines Inc. injection molding machines, ranging from 10 to 33 tons in vertical and horizontal configurations.

“Micromold brings with it over 40 years of expertise from mold design to end customer fulfillment service that allows us to expand our services and capabilities to our growing customer base,” Arterex North America President Bill Gerard said in a news release. “The company is an ideal addition to our offering of high-quality precision injection molded medical components, assemblies, product design and development services.”

Scottsdale, Arizona-based Arterex said Micromold will continue its 24/7 operations within Arterex’s Formula Plastics division in Tecate, Mexico, where Arterex has a 3,000 ft², Class 8 clean room. The company will continue serving medical, diagnostics, optical, dental and laboratory customers working under ISO 13485:2016 for quality management at the FDA-registered facility.

Launched in 2022 by London-based private equity firm Investindustria, Arterex offers diversified manufacturing services for medical device and life sciences customers. Arterex has more than 1,200 employees and manufacturing facilities in the U.S., Mexico, Italy and Egypt.